WASHINGTON -- Health secretary nominee Xavier Becerra told senators Tuesday that confronting the coronavirus pandemic will be his first priority if confirmed, but he also pledged to expand health insurance, rein in prescription drug costs and reduce racial and ethnic disparities in medical care.
"To meet this moment, we need strong federal leadership," Becerra said at the first of two hearings on his nomination. "I understand the enormous challenges before us and our solemn responsibility to faithfully steward this agency that touches almost every aspect of our lives."
Becerra now serves as California's attorney general and previously represented the Los Angeles area for more than 20 years in the U.S. House. A liberal politician-lawyer, he faces opposition from many GOP senators, who question his support for abortion rights and government-run health insurance, along with his lack of a clinical background. However, in the past 25 years, only one medical doctor has led the Department of Health and Human Services in a permanent capacity.
Appearing before the Senate health committee, Becerra seconded President Joe Biden's goals of 100 million vaccine shots in his first 100 days, increased coronavirus testing, ramped-up DNA mapping of the virus to track worrisome mutations and reopening schools and businesses.
On health insurance, he pledged to work to expand the Obama-era Patient Protection and Affordable Care Act, though in the past he's supported a government-run system like Sen. Bernie Sanders' "Medicare for All" idea. He said he would act to lower drug prices, particularly the cost of insulin. It's a goal that has bipartisan backing. Republican Sen. Mike Braun of Indiana noted that Becerra seems to have no drug industry support, adding, "I think I know why."
Although leading Republicans are portraying Becerra as unfit, Democrats seem unfazed about his prospects, accusing the GOP of playing politics despite the urgency of dealing with the coronavirus pandemic.
Becerra "has fought against pharmaceutical companies, opioid manufacturers, tobacco companies and polluters, and for more affordable quality health care for every patient," said health committee chair Sen. Patty Murray, D-Wash. "I have no doubt that, as secretary, he will put special interests on notice, patients and public health first, and put science, data and experts back in the driver's seat."
After Tuesday's appearance before the Health, Education, Labor and Pensions Committee, Becerra will be questioned today by the Finance Committee, which will vote on sending his nomination to the Senate floor. If confirmed, he'd be the first Hispanic to head Health and Human Services, a $1.4 trillion agency with a broad portfolio that includes health insurance programs, drug safety and approvals, advanced medical research and the welfare of children.
Sen. Richard Burr of North Carolina, the ranking Republican on the health committee, left no doubt that Becerra faces tough scrutiny.
[Video not showing up above? Click here to watch » https://www.youtube.com/watch?v=A3Hww3fCnko]
"I'm not sold yet," Burr said at Tuesday's hearing. "I'm not sure that you have the necessary experience or skills to do this job at this moment." Burr questioned whether Becerra respects the role of private companies in the health care system, particularly innovative pharmaceutical firms.
But other Republican senators sidestepped ideological confrontation and asked questions that centered on home state concerns. Sen. Tommy Tuberville, R-Ala., made a reference to "when" Becerra is confirmed, not "if." And Sen. Lisa Murkowski, R-Alaska, said she would encourage him to visit her state early.
Becerra sought to soften his image as an enemy of drug companies. "We need the pharmaceutical industry in America to always feel like we've got their back to innovate," he told Sen. Chris Murphy, D-Conn. "Covid is a perfect example of how we can come up with a vaccine, but we have to make sure that we're getting our dollar's worth."
And he also credited the Trump administration for its shepherding of two highly effective coronavirus vaccines. "There are a lot of people to thank, but without the work that the previous administration did, we would certainly not be here," he told Braun.
Information for this article was contributed by Kathleen Ronayne of The Associated Press.
